Collective and Individual Assessment of the Risk of Death from COVID-19 for the Elderly, 2020–2022

Introduction Coronavirus disease 2019 (COVID-19) has had profound disruptions worldwide. For a population or individual, it is critical to assess the risk of death for making preventative decisions. Methods In this study, clinical data from approximately 100 million cases were statistically analyzed. A software and an online assessment tool were developed in Python to evaluate the risk of mortality. Results Our analysis revealed that 76.51% of COVID-19-related fatalities occurred among individuals aged over 65 years, with frailty-associated deaths accounting for more than 80% of these cases. Furthermore, over 80% of the reported deaths involved unvaccinated individuals. A notable overlap was observed between aging and frailty-associated deaths, both of which were connected to underlying health conditions. For those with at least two comorbidities, the proportion of frailty and the proportion of COVID-19-related death were both close to 75 percent. Subsequently, we established a formula to calculate the number of deaths, which was validated using data from twenty countries and regions. Using this formula, we developed and verified an intelligent software designed to predict the death risk for a given population. To facilitate rapid risk screening on an individual level, we also introduced a six-question online assessment tool. Conclusions This study examined the impact of underlying diseases, frailty, age, and vaccination history on COVID-19-related mortality, resulting in a sophisticated software and a user-friendly online scale to assess mortality risk. These tools offer valuable assistance in informed decision-making.

[1]  Hongzhi Wang,et al.  Asymptomatic Transmissibility Calls for Implementing a Zero-COVID Strategy to End the Current Global Crisis , 2022, Frontiers in Cellular and Infection Microbiology.

[2]  Yudan Ding,et al.  Epidemiological, Radiographical, and Laboratorial Characteristics of Chinese Asymptomatic Cases With COVID-19: A Systematic Review and Meta-Analysis , 2022, Frontiers in Public Health.

[3]  M. Hernán,et al.  Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study , 2021, The Lancet.

[4]  Zhongjie Li,et al.  Risk Factors for Death Among the First 80 543 Coronavirus Disease 2019 (COVID-19) Cases in China: Relationships Between Age, Underlying Disease, Case Severity, and Region , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  Xiangqi Li,et al.  K-SEIR-Sim: A simple customized software for simulating the spread of infectious diseases , 2021, Computational and Structural Biotechnology Journal.

[6]  Eefje G. J. Roelofsen,et al.  Association between Clinical Frailty Scale score and hospital mortality in adult patients with COVID-19 (COMET): an international, multicentre, retrospective, observational cohort study , 2021, The Lancet Healthy Longevity.

[7]  F. Elzein,et al.  Reinfection, recurrence, or delayed presentation of COVID-19? Case series and review of the literature , 2021, Journal of Infection and Public Health.

[8]  D. Molloy,et al.  Prevalence of frailty in 62 countries across the world: a systematic review and meta-analysis of population-level studies. , 2020, Age and ageing.

[9]  R. Harwood,et al.  Association of Frailty with Mortality in Older Inpatients with Covid-19: A Cohort Study , 2020, Age and ageing.

[10]  J. Woo,et al.  Management of frailty: opportunities, challenges, and future directions , 2019, The Lancet.

[11]  T. Strandberg,et al.  Frailty in elderly people , 2007, The Lancet.